Analyst Activity – Roth Capital Initiates Coverage On NASDAQ:APVO – Aptevo Therapeutics (NASDAQ:APVO) With a Buy

Analyst Ratings For NASDAQ:APVO – Aptevo Therapeutics (NASDAQ:APVO)

Today, Roth Capital initiated coverage on NASDAQ:APVO – Aptevo Therapeutics (NASDAQ:APVO) with a Buy with a price target of $12.00.

Some recent analyst ratings include

  • 4/11/2018-Roth Capital initiated coverage with a Buy rating.
  • 10/5/2017-Piper Jaffray Reiterated Rating of Overweight .

Recent Insider Trading Activity For NASDAQ:APVO – Aptevo Therapeutics (NASDAQ:APVO)
NASDAQ:APVO – Aptevo Therapeutics (NASDAQ:APVO) has insider ownership of 15.60% and institutional ownership of 33.04%.

  • On 3/19/2018 Marvin L White, Insider, sold 100,000 with an average share price of $2.93 per share and the total transaction amounting to $293,000.00.
  • On 11/15/2017 Randy Joe Maddux, VP, bought 25,000 with an average share price of $2.76 per share and the total transaction amounting to $69,000.00.

Recent Trading Activity for NASDAQ:APVO – Aptevo Therapeutics (NASDAQ:APVO)
Shares of NASDAQ:APVO – Aptevo Therapeutics closed the previous trading session at 3.59 up +0.31 9.47% with 3.4600000381469727 shares trading hands.

An ad to help with our costs